<SEC-DOCUMENT>0001104659-22-078840-index.html : 20220711 <SEC-HEADER>0001104659-22-078840.hdr.sgml : 20220711 <ACCEPTANCE-DATETIME>20220711165313 ACCESSION NUMBER: 0001104659-22-078840 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20220811 FILED AS OF DATE: 20220711 DATE AS OF CHANGE: 20220711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 221077405 BUSINESS ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: D01 H104 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 414 COMMERCE DRIVE STREET 2: STE 120 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>DEF 14A <SEQUENCE>1 <FILENAME>tm2219814-2_def14a.htm <DESCRIPTION>DEF 14A <TEXT> Document 1 - file: tm2219814-2_def14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>lg_nabriva-4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: lg_nabriva-4c.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>tm2219814d1-px_page02bw.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: tm2219814d1-px_page02bw.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>tm2219814d2-px_page01bw.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: tm2219814d2-px_page01bw.jpg
</DOCUMENT> </SEC-DOCUMENT>